Like so many innovations, the ideas that launched SelSym Biotech emerged over a few cups of coffee and some furious scribbling on napkins. Those conversations led to a remarkable collaboration between ambitious scientists, engineers, and clinicians – all of whom were driven to address the key unmet clinical needs in trauma and hemorrhage treatment and management.

 

Now more than a decade later, those ideas have become the foundation of the Hemostatic Healing Hydrogel platform, and our lead product, SymClot. SelSym’s innovative platelet-mimetic technology suite hold tremendous promise in transforming the care of traumatic injury, post-surgical bleeding, wound care, and tissue regeneration.